← Holders
Enavate Sciences GP, LLC
What Enavate Sciences GP, LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1953107 · Filed Nov 16, 2026
- Positions
- 8
- Reported value
- $279.8M
- Opened
- 1
- Closed
- 0
- Other managers included
- 0
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$327.5M7 positions
- Dec 31, 2025$506.8M7 positions
- Mar 31, 2026$351.5M7 positions
- Jun 30, 2026$345.4M7 positions
- Sep 30, 2026$279.8M8 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
ZBIOZenas BioPharma, Inc. | 2.9M | −25.5% | $78.7M | 28.1% |
IMNMImmunome Inc. | 3.6M | ±0% | $77.7M | 27.8% |
BRVEBraveheart Bio, Inc. | 3.7M | New | $74.2M | 26.5% |
SIONSionna Therapeutics, Inc. | 2.5M | ±0% | $13M | 4.7% |
UPBUpstream Bio, Inc. | 2.5M | ±0% | $13M | 4.6% |
BBOTBridgeBio Oncology Therapeutics, Inc. | 2.6M | ±0% | $10.8M | 3.8% |
CMPXCompass Therapeutics, Inc. | 7.8M | ±0% | $8.1M | 2.9% |
CAMPCamp4 Therapeutics Corp | 1M | −27.0% | $4.2M | 1.5% |